Makena's accelerated approval withdrawal hearing set for October as Covis wants to do more research
The long-awaited FDA hearing to review Covis Pharma’s accelerated approval for its controversial preterm birth injection, which failed its confirmatory trial, will take place from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.